Translumina Therapeutics Llp - Company Profile

Q: Who are the current directors of Translumina Therapeutics Llp?

The current directors of Translumina Therapeutics Llp are Vishal Sharma, Indranil Mukherjee, Gurmit Singh Chugh, Avnish Mehra, Punita Sharma, Vishal Omprakash Goenka.

It is a healthcare limited liability partnership based in New Delhi, Delhi, India, established in 2009.

2009 New Delhi, Delhi, India Converted And Dissolved

Last Updated: July 14, 2025

Access Report

About Translumina Therapeutics Llp

Translumina Therapeutics Llp, a converted and dissolved limited liability partnership, was established on 01 December 2009 in New Delhi, Delhi, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds LLPIN: AAA-0435. Registered under ROC Roc Delhi. It has total obligation of contribution of ₹0.10 M.

Employing 363 professional, Its leadership includes Vishal Sharma (Designated Partner), Indranil Mukherjee (Designated Partner), Gurmit Singh Chugh (Partner). Past directors included Gurmit Singh Chugh, Avnish Mehra. It holds ₹60.95 Cr open charges and ₹9.25 Cr settled loans. Its latest date of accounts and solvency statement 31 March 2024. It is based at Ground Floor, Metro Tower Lsc,Mor Land, New Rajinder Nagar, New Delhi, Delhi, 110060.

Company Details

CIN/LLPIN
AAA-0435
Incorporation Date
01 December 2009
Total Obligation of Contribution
₹0.10 M
ROC Code
Roc Delhi
Company Status
Converted And Dissolved

Key Metrics

Obligation of Contribution ₹ 0.10 M as on 14-07-2025
Company Age 16 Year, 2 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 60.95 Cr as on 14-07-2025
Satisfied Charges ₹ 9.25 Cr as on 14-07-2025
Revenue Growth **** -11.84% (FY 2021)
Profit Growth **** -36.98% (FY 2021)
Ebitda **** -17.32% (FY 2021)
Total Assets -1.80% (FY 2021)

Comprehensive Company Insights

Explore comprehensive insights into Translumina Therapeutics Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Translumina Therapeutics Llp?

Current Designated Partners

Name	Designation	Appointment Date	Status
Vishal Sharma	Designated Partner	11 Mar 2020	Current
Indranil Mukherjee	Designated Partner	15 Mar 2024	Current
Gurmit Singh Chugh	Partner	17 May 2019	Current
Avnish Mehra	Partner	11 Mar 2020	Current
Punita Sharma	Designated Partner	01 Dec 2009	Current
Vishal Omprakash Goenka	Designated Partner	15 Mar 2024	Current

Past Designated Partners

Name	Designation	Cessation	Status
Pramod Abcsdd	Designated Partner	10 May 2019	Past
Pramod Abcsdd	Designated Partner	10 Mar 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Translumina Therapeutics Llp.

Translumina Therapeutics Llp, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.84% decrease. The company also saw a substantial fall in profitability, with a 36.98% decrease in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-11.84%

*******

Revenue from Operations

*******

-12.60%

*******

Total Assets

*******

-1.80%

*******

Profit or Loss

*******

-36.98%

*******

Net Worth

*******

EBITDA

*******

-17.32%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Translumina Therapeutics Llp?

Unlock access to Translumina Therapeutics Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹609,503,560.00

Satisfied Charges

₹92,500,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 50.55 Cr
Icici Bank Limited : 10.00 Cr
Axis Bank Limited : 0.40 Cr

Latest Charge Details

Date	Lender	Amount	Status
18 Nov 2022	Hdfc Bank Limited	₹2.30 M	Open
30 Aug 2022	Icici Bank Limited	₹10.00 Cr	Open
20 Apr 2022	Hdfc Bank Limited	₹1.61 M	Open
28 Jan 2022	Hdfc Bank Limited	₹50.00 Cr	Open
27 Nov 2021	Hdfc Bank Limited	₹0.80 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Translumina Therapeutics Llp?

Translumina Therapeutics Llp has a workforce of 363 employees as of Feb 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Translumina Therapeutics Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Translumina Therapeutics Llp's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Translumina Therapeutics Llp

Recent Activity within the Organization

Annual General Meeting

Translumina Therapeutics Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was recorded as a recent event.
31 Mar 2024
Statement of Assets & Liabilities

The activity Translumina Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
31 Mar 2024
Director Appointment

Progress on Indranil Mukherjee was appointed as a Designated Partner was appointed as a Designated Partner on 15 Mar 2024 & has been associated with this company since 1 year 10 months . was documented.
15 Mar 2024
Director Appointment

Vishal Omprakash Goenka was appointed as a Designated Partner was appointed as a Designated Partner on 15 Mar 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
15 Mar 2024
Charges

Progress on A charge with Hdfc Bank Limited of Rs. 500.00 M registered on 28 Jan 2022 with Charge ID 100534152 was modified on 21 Mar 2023. was documented.
21 Mar 2023
Charges

Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.30 M with Charge ID 100654416 was registered on 18 Nov 2022. was documented.
18 Nov 2022

Explore recent activity and updates - View Recent Activity